ENXTAM:SBMO
ENXTAM:SBMOEnergy Services

SBM Offshore (ENXTAM:SBMO): Assessing Valuation After Strong Year-to-Date Share Price Gains

SBM Offshore (ENXTAM:SBMO) shares have drawn attention this month, rising alongside steady gains in the energy sector. Investors are taking notice as the company posts healthy returns and shows solid year-to-date performance. See our latest analysis for SBM Offshore. SBM Offshore’s latest surge comes after a steady climb this year, with the share price up 44.8% year-to-date and achieving a robust 49.1% total shareholder return over the past twelve months. Momentum appears strong, building off...
ENXTAM:WKL
ENXTAM:WKLProfessional Services

Will Wolters Kluwer's (ENXTAM:WKL) AWS Push Reshape Its Cloud Value Proposition for CFOs?

Wolters Kluwer has launched its AI-powered CCH Tagetik Intelligent Platform on AWS Marketplace as a private offer, enabling enterprise clients to access advanced financial management solutions with customized pricing and streamlined cloud procurement. This initiative allows customers to leverage advanced AI features, flexible licensing, and AWS billing integration, potentially accelerating cloud adoption for CFO offices and enhancing value through financial workflow automation. We'll explore...
ENXTAM:FUR
ENXTAM:FURConstruction

Fugro (ENXTAM:FUR) Valuation in Focus Following Q3 2025 Sales and Trading Statement Release

Fugro (ENXTAM:FUR) drew market attention following its Q3 2025 sales and trading statement call on October 31. This routine event often provides investors with fresh insights into company performance and outlook. See our latest analysis for Fugro. While Fugro’s Q3 update has stirred fresh interest, the company’s momentum remains challenged, with a year-to-date share price return of -49.27% and a one-year total shareholder return of -42.55%. Despite some short-term upticks, longer-term...
ENXTAM:PHIA
ENXTAM:PHIAMedical Equipment

Can Steady Profitability Amid Modest Sales Shift Reveal Philips’ Transformation Strategy? (ENXTAM:PHIA)

Earlier this month, Koninklijke Philips reported its third-quarter 2025 earnings, posting sales of €4.30 billion and net income of €184 million, alongside reiterating its full-year guidance for 1%-3% comparable sales growth. An interesting insight is that while sales slipped slightly compared to the prior year, Philips' profitability and earnings per share remained stable, offering consistency during a period of transformation for the company. We’ll now explore how this steady earnings...
ENXTAM:FLOW
ENXTAM:FLOWCapital Markets

How Weaker Earnings and New Credit Facilities At Flow Traders (ENXTAM:FLOW) Have Changed Its Investment Story

Flow Traders Ltd. recently reported earnings for the nine months ended September 30, 2025, showing declines in sales to €78.3 million, revenue to €80.5 million, and net income to €10.9 million, compared to the same period last year. Alongside the weaker financial results, the company secured a US$200 million private credit facility and a US$75 million revolving credit facility to support its trading capital needs, highlighting ongoing efforts to strengthen operational capacity. We'll now...
ENXTAM:BNJ
ENXTAM:BNJEntertainment

Do Delayed Revenues at Banijay Group (ENXTAM:BNJ) Reveal a Shift in Long-Term Growth Focus?

Banijay Group N.V. recently reported its earnings for the nine months ended September 30, 2025, showing sales of €3.22 billion and net income of €118.7 million, along with an update on annual guidance pointing to low-single digit growth in Entertainment & Live and around 10% growth at Banijay Gaming following a temporary hit from adverse sports results. An important detail emerging from these announcements is the company's decision to postpone some content deliveries to early 2026, paired...
ENXTAM:CCEP
ENXTAM:CCEPBeverage

Coca-Cola Europacific Partners (ENXTAM:CCEP) Raises Dividend After Reaffirming 2025 Outlook—Has Confidence Peaked?

On November 5, 2025, Coca-Cola Europacific Partners reaffirmed its 2025 earnings guidance, posted year-to-date revenue of €15.68 billion, and declared an increased interim dividend, resulting in a full-year dividend payout ratio of approximately 50%. Management's confidence in delivering both revenue and profit growth, alongside an enhanced dividend, reflects ongoing operational strength and a continued focus on shareholder returns. We'll explore how the reaffirmed earnings outlook and...
ENXTAM:FUR
ENXTAM:FURConstruction

What Fugro (ENXTAM:FUR)'s Removal from the Euronext 150 Index May Mean for Shareholders

On October 31, 2025, Fugro was removed from the Euronext 150 Index, coinciding with the release of its Q3 2025 sales and trading statement call. Index removals often impact trading volumes and stock demand, as index-tracking funds must adjust their portfolios to reflect constituent changes. Given the influence of index removals on institutional trading, we’ll explore how this development may shape Fugro’s broader investment narrative. AI is about to change healthcare. These 32 stocks are...
ENXTAM:ECMPA
ENXTAM:ECMPARetail REITs

Did Eurocommercial Properties' (ENXTAM:ECMPA) Rising Revenue Without Profit Growth Just Shift Its Investment Narrative?

Eurocommercial Properties N.V. has reported its earnings for the nine months ended September 30, 2025, with sales of €170.56 million and revenue of €203.31 million, both higher than the previous year, but with net income dropping to €74.53 million from €93.6 million a year ago. This performance highlights a situation where top-line growth did not translate into higher net profits, as both basic and diluted earnings per share from continuing operations also saw a decrease year-on-year. To...
ENXTAM:EXO
ENXTAM:EXODiversified Financial

How Euronext 100 Inclusion and €600 Million Debt Issuance at Exor (ENXTAM:EXO) Has Changed Its Investment Story

Exor N.V. was recently added to the Euronext 100 Index and completed the settlement of a €600 million debt offering with a 3.75% annual coupon, due in 2035 and listed on the Luxembourg Stock Exchange. Index inclusion can influence trading activity as investment funds tracking the Euronext 100 may increase their holdings of Exor. We'll examine how Exor’s index addition shapes its investment narrative, particularly regarding visibility among institutional investors. Uncover the next big thing...
ENXTAM:FFARM
ENXTAM:FFARMFood

ForFarmers And 2 Other European Penny Stocks To Watch

European markets have recently experienced a pullback, with the pan-European STOXX Europe 600 Index ending lower amid concerns about overvaluation in artificial intelligence-related stocks. In this context, investors often seek out opportunities that offer potential growth without excessive risk. Penny stocks, though an older term, remain relevant as they represent smaller or newer companies that can provide value and growth potential. By focusing on those with strong financials and solid...
ENXTAM:INPST
ENXTAM:INPSTLogistics

InPost (ENXTAM:INPST) Valuation: Weighing Growth Potential After Mixed Q3 Earnings

InPost (ENXTAM:INPST) released its third quarter earnings and reported sales growth to PLN 3,768.9 million. Net income dipped to PLN 170.7 million compared to the same period last year. See our latest analysis for InPost. After reporting strong revenue growth but sliding net income, InPost’s share price momentum has continued to cool off. The stock currently trades at €10.05, with a year-to-date share price return of -39.78%. Over the past twelve months, total shareholder return stands at...
ENXTAM:PHARM
ENXTAM:PHARMBiotechs

Why Pharming Group (ENXTAM:PHARM) Is Up 22.9% After Raising Guidance and Leniolisib’s FDA Progress

On November 6, 2025, Pharming Group N.V. reported strong quarterly earnings with nine-month sales of US$269.6 million, up from US$204.53 million the previous year, and raised its full-year 2025 revenue guidance to between US$365 million and US$375 million. A key development was the company's announcement that the FDA granted priority review for leniolisib's potential pediatric label expansion, signaling further growth opportunities for its rare disease portfolio. With robust revenue momentum...
ENXTAM:PRX
ENXTAM:PRXMultiline Retail

Is Prosus Still a Smart Bet After Its 53.9% Gain and Tech Portfolio Shakeup?

Ever wondered if Prosus could be your next smart investment? Let’s pull back the curtain on its true value and see if the current price stacks up to reality. After a standout year with gains of 53.9%, Prosus’ shares have seen some recent volatility, dipping 1.6% in the past week and 5.5% over the past month. However, they remain up an impressive 52.7% year-to-date. Behind these moves, market watchers are eyeing news like Prosus’s continued tech investments and portfolio reshuffling, as well...
ENXTAM:AMG
ENXTAM:AMGMetals and Mining

AMG Critical Materials (ENXTAM:AMG): How Bullish Narratives Look After Latest Results

AMG Critical Materials (ENXTAM:AMG) posted a strong set of headline numbers, with earnings forecast to grow 39.9% per year, well ahead of the Dutch market’s 11.2% growth rate. Revenue, meanwhile, is expected to rise 4.7% annually, trailing the broader market’s 7.8%. The company has recently returned to profitability and has grown earnings by 7.4% per year over the past five years.